Sunlight AI Secures $17.4M to Scale Operating Infrastructure and Collections for Independent Physicians21. Oktober 2026
News AbbVie Acquires Gilgamesh’s Psychedelic MDD Program for up to $1.2BHealthradar26. August 2025 What You Should Know: – AbbVie and Gilgamesh Pharmaceuticals Inc. have announced a definitive agreement for AbbVie to acquire Gilgamesh’s…
